209 related articles for article (PubMed ID: 35777330)
61. Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Kartal P; Vriends ALM; French PJ; van Royen ME; Taal W; Sleijfer S; Wiemer EAC
Sci Rep; 2020 Feb; 10(1):2927. PubMed ID: 32076030
[TBL] [Abstract][Full Text] [Related]
62. Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.
Lu HC; Eulo V; Apicelli AJ; Pekmezci M; Tao Y; Luo J; Hirbe AC; Dahiya S
Oncotarget; 2018 May; 9(33):23018-23028. PubMed ID: 29796169
[TBL] [Abstract][Full Text] [Related]
63. Other Nerve Sheath Tumors of Brain and Spinal Cord.
Petrov M; Sakelarova T; Gerganov V
Adv Exp Med Biol; 2023; 1405():363-376. PubMed ID: 37452945
[TBL] [Abstract][Full Text] [Related]
64. Expression and function of somatostatin receptors in peripheral nerve sheath tumors.
Mawrin C; Schulz S; Hellwig-Patyk A; Kirches E; Roessner A; Lendeckel U; Firsching R; Vorwerk CK; Keilhoff G; Dietzmann K; Grimm K; Lindberg G; Gutmann DH; Scheithauer BW; Perry A
J Neuropathol Exp Neurol; 2005 Dec; 64(12):1080-8. PubMed ID: 16319718
[TBL] [Abstract][Full Text] [Related]
65. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
66. Malignant Peripheral Nerve Sheath Tumor.
James AW; Shurell E; Singh A; Dry SM; Eilber FC
Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
[TBL] [Abstract][Full Text] [Related]
67. Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.
Kobayashi D; Hirayama M; Komohara Y; Mizuguchi S; Wilson Morifuji M; Ihn H; Takeya M; Kuramochi A; Araki N
J Biol Chem; 2014 Sep; 289(38):26314-26326. PubMed ID: 25092287
[TBL] [Abstract][Full Text] [Related]
68. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.
Mautner VF; Asuagbor FA; Dombi E; Fünsterer C; Kluwe L; Wenzel R; Widemann BC; Friedman JM
Neuro Oncol; 2008 Aug; 10(4):593-8. PubMed ID: 18559970
[TBL] [Abstract][Full Text] [Related]
69. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract][Full Text] [Related]
70. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
Liapis H; Marley EF; Lin Y; Dehner LP
Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
[TBL] [Abstract][Full Text] [Related]
71. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
[TBL] [Abstract][Full Text] [Related]
72. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
73. Nerve ultrasound in neurofibromatosis type 1: A follow-up study.
Telleman JA; Stellingwerff MD; Brekelmans GJ; Visser LH
Clin Neurophysiol; 2018 Feb; 129(2):354-359. PubMed ID: 29288991
[TBL] [Abstract][Full Text] [Related]
74. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours.
Bottillo I; Ahlquist T; Brekke H; Danielsen SA; van den Berg E; Mertens F; Lothe RA; Dallapiccola B
J Pathol; 2009 Apr; 217(5):693-701. PubMed ID: 19142971
[TBL] [Abstract][Full Text] [Related]
75. Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.
Sun D; Xie XP; Zhang X; Wang Z; Sait SF; Iyer SV; Chen YJ; Brown R; Laks DR; Chipman ME; Shern JF; Parada LF
Cell Stem Cell; 2021 Aug; 28(8):1397-1410.e4. PubMed ID: 34010628
[TBL] [Abstract][Full Text] [Related]
76. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
[TBL] [Abstract][Full Text] [Related]
77. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB.
Dang I; DeVries GH
J Neurosci Res; 2005 Feb; 79(3):318-28. PubMed ID: 15602756
[TBL] [Abstract][Full Text] [Related]
78. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.
Suppiah S; Mansouri S; Mamatjan Y; Liu JC; Bhunia MM; Patil V; Rath P; Mehani B; Heir P; Bunda S; Velez-Reyes GL; Singh O; Ijad N; Pirouzmand N; Dalcourt T; Meng Y; Karimi S; Wei Q; Nassiri F; Pugh TJ; Bader GD; Aldape KD; Largaespada DA; Zadeh G
Nat Commun; 2023 May; 14(1):2696. PubMed ID: 37164978
[TBL] [Abstract][Full Text] [Related]
79. FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner.
Aimaier R; Chung MH; Gu Y; Yu Q; Wei C; Li H; Guo Z; Long M; Li Y; Wang W; Li Q; Wang Z
Cancer Gene Ther; 2023 Oct; 30(10):1390-1402. PubMed ID: 37488294
[TBL] [Abstract][Full Text] [Related]
80. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
Jessen WJ; Miller SJ; Jousma E; Wu J; Rizvi TA; Brundage ME; Eaves D; Widemann B; Kim MO; Dombi E; Sabo J; Hardiman Dudley A; Niwa-Kawakita M; Page GP; Giovannini M; Aronow BJ; Cripe TP; Ratner N
J Clin Invest; 2013 Jan; 123(1):340-7. PubMed ID: 23221341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
